Frank Qin is an Investor at AstraZeneca, whose known portfolio counts 12 companies.
Is Frank Qin a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Investor at AstraZeneca, whose known portfolio counts 12 companies
- Syneron
- HUMA
- Nucleus RadioPharma
- Asher Bio
- Creech Medical Technology Development
- Rgenta Therapeutics
- SmartCella
- Axbio
- Cellectis
- GenAssist Therapeutics
- Promise Bio
- SixPeaks Bio
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Corporate-Strategic, Diagnostics and Drug Discovery. Startups operating in these areas may find Frank Qin relevant.
AstraZeneca appears in Growth, Late-Stage and Seed rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Frank Qin matches their raise.
Colleagues at AstraZeneca
Maya Leo Aridi
Venture Capital
Washington, United States
Alexander Kvist
Senior Project Leader, Bioventure Innovation Unit
Gothenburg, Sweden
Sanne Weijzen
Head of Cell Therapy Business and Portfolio Strategy
Hilversum, Netherlands
Ulrika Edvardsson
Managing Director BioVentureHub
Gothenburg, Sweden
Preya Subramoney
Senior Medical Director
Denmark
Demi Weldon
Executive Director
San Francisco, United States
Peter Fenici
Head of Medical Innovation
Italy
Cherry Zhang
Associate Director
Singapore
Pernilla Isberg
Director BioVentureHub
Gothenburg, Sweden
Annie Vemu
Director, CI New Technologies & Platforms
Boston, United States
Laura Wright
Managing Partner FTS
Washington, United States
Crystal Brooks
Corporate Ventures Associate Director
United States
André Verhoek
Principial and founder, PhD Candidate
Barcelona, Spain
Daniel Johansson
Project Leader
Kungsbacka, Sweden
Robert Roth
Science Director BioVentureHub
Gothenburg, Sweden
Yani Wang
Director, Venture Investment & BD
Ithaca, United States
Frequently asked questions
Who is Frank Qin?
Frank Qin is a corporate venture investor based in United States, listed as Investor at AstraZeneca. The known portfolio of that firm counts 12 companies. That portfolio belongs to the firm, not to Frank Qin personally.
What does Frank Qin invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Corporate-Strategic, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Frank Qin invest at?
AstraZeneca appears in Growth, Late-Stage and Seed rounds across its known deals, and Frank Qin is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Frank Qin listed at?
Frank Qin is listed as Investor at AstraZeneca. 16 other people in the database share a firm with Frank Qin.
How do I contact Frank Qin?
A LinkedIn page is on file for Frank Qin. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal